CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
CNO Financial Group, Inc. (CNO) is the issuer in a notice filed for a proposed sale of its common stock under Rule 144 by officer Karen DeToro. The notice covers up to 9,374 shares of common stock, with an aggregate market value of $515,366.21, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 31, 2026. The shares consist of 7,500 shares underlying stock options expected to be exercised for cash on August 31, 2026, and 1,874 shares of restricted stock issuable on March 25, 2025.
CNO Financial Group, Inc. (CNO) is the issuer of common stock that officer Jeanne Lynn Linnenbringer has filed a notice to potentially sell under Rule 144. The notice covers up to 6,560 shares of CNO common stock, with an indicated aggregate market value of $360,715.51, and lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker. The shares relate to 5,010 shares from a stock option exercise dated August 31, 2026 and 1,550 performance shares dated February 15, 2022, with a proposed sale date of August 31, 2026 on the NYSE.
CNO Financial Group, Inc. filed a quarterly Form 13F institutional investment manager holdings report. The report covers 18 reportable positions with a total reported value of 174,661,572 (round to the nearest dollar). The filing also notes 1 other included manager, 40/86 Advisors, Inc.
CNO Financial Group, Inc. reported higher results for the quarter and six months ended June 30, 2026. Total revenues were $1,285.2 million for the quarter, up from $1,151.5 million a year earlier, and net income rose to $125.9 million from $91.8 million, with diluted EPS increasing to $1.33 from $0.91. For the first six months, revenues were $2,314.8 million and net income $163.6 million, compared to $2,155.6 million and $113.3 million in 2025.
Total assets increased to $39,861.2 million as of June 30, 2026, while shareholders’ equity was $2,591.6 million. The investment portfolio reached $30,742.9 million, and cash and cash equivalents (including those held by variable interest entities) were $1,306.0 million. The company continued returning capital through common stock repurchases of $120.0 million and common dividends of $33.5 million in the first half of 2026, and exited its Worksite fee services business as of June 30, 2026.
CNO Financial Group, Inc. reported strong second quarter 2026 results and raised its 2026 operating earnings per share guidance by 8% at the midpoint. Net income was $125.9 million, or $1.33 per diluted share, and net operating income was $119.5 million, or $1.26 per diluted share.
Total revenues were $1,285.2 million, and operating EPS grew 45% year-over-year. The trailing four-quarter return on equity was 10.9%, with operating ROE excluding significant items at 13.1%. Book value per diluted share excluding accumulated other comprehensive loss was $39.92. New annualized premiums rose 7%, marking the 16th consecutive quarter of insurance sales growth. CNO repurchased $60.0 million of common stock and paid $16.8 million in common dividends during the quarter.
CNO submitted a Form 144 notice reporting the proposed sale of restricted common stock and recent dispositions by a holder. The filing lists three past transfers in June 2026: 5,750 shares ($287,500) on 06/11/2026, 3,308 shares ($162,092) on 06/10/2026, and 4,808 shares ($225,976) on 06/02/2026. The header lists 93,348,503 shares with an associated date of 07/01/2026.
CNO Financial Group CEO Gary C. Bhojwani reported a combination of option exercises and stock sales. He exercised 44,250 Employee Stock Options at an exercise price of $21.06 per share, converting them into common stock, and then sold a total of 86,048 common shares in two open-market transactions at weighted average prices of about $51.48 per share pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026. After these transactions, he held 174,264 common shares directly and 651,189 common shares indirectly through the Gary C. Bhojwani Revocable Trust.
CNO Financial Group Chief Marketing Officer Rocco F. Tarasi III sold 1,891 shares of common stock in an open-market transaction at a price of $51.31 per share. After this sale, he directly holds 77,300 shares of CNO common stock.
The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 24, 2026, indicating it was scheduled in advance rather than timed discretionarily.
CNO Financial Group (CNO) filing a Section 144 notice for proposed sales of Common Stock by a broker-dealer account. The filing lists a reported value of $4,429,456.76 and a reference figure of 93,348,503 dated 06/30/2026. The schedule shows 44,250 shares tied to a Stock Option Exercise on 06/30/2026 and 41,798 shares identified as Restricted Stock with a 03/25/2026 date.
CNO notice of proposed sale of 5,750 shares of Common Stock by means of a stock option exercise to be effected on 06/11/2026. The filing lists the sale method as cash and identifies the transaction party as ISSUER.
The excerpt also records recent sales by Rocco Tarasi: 3,308 shares sold on 06/10/2026 for $162,092 and 4,808 shares sold on 06/02/2026 for $225,976.